| Old Articles: <Older 47171-47180 Newer> |
|---|
 |
The Motley Fool
February 15, 2011
Rich Smith |
What's Behind the Run-Up at Exelixis? One word: earnings. Shares of this tiny drug developer have taken off like a rocket.   |
The Motley Fool
February 15, 2011
Anders Bylund |
Ultra Clean Technologies, Sloppy Operations There's nothing clean about Ultra Clean's chaotic execution. |
The Motley Fool
February 15, 2011
Tim Beyers |
This Stock Will Profit From the Coming Chip Rally Nanometrics is challenging peers to think smaller. |
The Motley Fool
February 15, 2011
Roger Friedman |
3 Buzz-Worthy Stocks to Watch A trio of stellar stocks for your consideration. |
The Motley Fool
February 15, 2011
Catherine Baab-Muguira |
Getting Hooked on Craft Brewers Alliance There's a lot to like about this brewer. |
The Motley Fool
February 15, 2011
Travis Hoium |
Insituform Technologies Shares Plunged: What You Need to Know Shares of Insituform Technologies fell 10% in trading late today. |
The Motley Fool
February 15, 2011
Cliff D'Arcy |
Barclays Banks Over 6 Billion Pounds Barclays' profit rises by a third, thanks to a big drop in write-offs. |
The Motley Fool
February 15, 2011
Brian Orelli |
Obama Hates Your Drugmaker The president's proposal in favor of earlier generics would mean lower profits for some companies. |
The Motley Fool
February 15, 2011
Matt Koppenheffer |
5 Value Stocks From the Bargain Bin Mr. Market is selling these stocks way too cheaply. |
The Motley Fool
February 15, 2011
Anders Bylund |
Limelight's Secret Sauce Is Not What You Think You know all about the Netflix deal, but Limelight loves its mobile customers even more. |
| <Older 47171-47180 Newer> Return to current articles. |
